agilon health inc. (AGL)
agilon health inc. Statistics
Share Statistics
agilon health inc. has 412.02M shares outstanding. The number of shares has increased by 0.6% in one year.
| Shares Outstanding | 412.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.13% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 303.29M |
| Failed to Deliver (FTD) Shares | 50 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 29.79M, so 7.23% of the outstanding shares have been sold short.
| Short Interest | 29.79M |
| Short % of Shares Out | 7.23% |
| Short % of Float | 9.82% |
| Short Ratio (days to cover) | 8.05 |
Valuation Ratios
The PE ratio is -19.54 and the forward PE ratio is -6.68.
| PE Ratio | -19.54 |
| Forward PE | -6.68 |
| PS Ratio | 1.19 |
| Forward PS | 0.2 |
| PB Ratio | 7.75 |
| P/FCF Ratio | -27.44 |
| PEG Ratio | n/a |
Enterprise Valuation
agilon health inc. has an Enterprise Value (EV) of 5.07B.
| EV / Earnings | -19.31 |
| EV / Sales | 1.17 |
| EV / EBITDA | -30.24 |
| EV / EBIT | -21.84 |
| EV / FCF | -27.11 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.51 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.08 |
| Total Debt / Capitalization | 7.32 |
| Cash Flow / Debt | -2.99 |
| Interest Coverage | -34.87 |
Financial Efficiency
Return on equity (ROE) is -0.4% and return on capital (ROIC) is -32.67%.
| Return on Equity (ROE) | -0.4% |
| Return on Assets (ROA) | -0.15% |
| Return on Capital (ROIC) | -32.67% |
| Revenue Per Employee | 3.86M |
| Profits Per Employee | -235.09K |
| Employee Count | 1.12K |
| Asset Turnover | 2.48 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 791.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -42.95% in the last 52 weeks. The beta is 0.6, so agilon health inc.'s price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -42.95% |
| 50-Day Moving Average | 2.24 |
| 200-Day Moving Average | 4.27 |
| Relative Strength Index (RSI) | 69.16 |
| Average Volume (20 Days) | 4.39M |
Income Statement
In the last 12 months, agilon health inc. had revenue of 4.32B and earned -262.60M in profits. Earnings per share was -0.64.
| Revenue | 4.32B |
| Gross Profit | 69.67M |
| Operating Income | -232.13M |
| Net Income | -262.60M |
| EBITDA | -167.64M |
| EBIT | -232.13M |
| Earnings Per Share (EPS) | -0.64 |
Balance Sheet
The company has 107.57M in cash and 52.31M in debt, giving a net cash position of 55.26M.
| Cash & Cash Equivalents | 107.57M |
| Total Debt | 52.31M |
| Net Cash | 55.26M |
| Retained Earnings | -1.33B |
| Total Assets | 2.09B |
| Working Capital | 402.60M |
Cash Flow
In the last 12 months, operating cash flow was -156.20M and capital expenditures -30.82M, giving a free cash flow of -187.01M.
| Operating Cash Flow | -156.20M |
| Capital Expenditures | -30.82M |
| Free Cash Flow | -187.01M |
| FCF Per Share | -0.46 |
Margins
Gross margin is 1.61%, with operating and profit margins of -5.38% and -6.08%.
| Gross Margin | 1.61% |
| Operating Margin | -5.38% |
| Pretax Margin | -4.51% |
| Profit Margin | -6.08% |
| EBITDA Margin | -3.88% |
| EBIT Margin | -5.38% |
| FCF Margin | -4.33% |
Dividends & Yields
AGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -18.82% |
| FCF Yield | -13.35% |
Analyst Forecast
The average price target for AGL is $3.08, which is -9.4% lower than the current price. The consensus rating is "Hold".
| Price Target | $3.08 |
| Price Target Difference | -9.4% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
Scores
| Altman Z-Score | 2 |
| Piotroski F-Score | 2 |